martes, 5 de noviembre de 2013

Long-Term Mortality after Screening for Colorectal Cancer — NEJM

full-text ►
Long-Term Mortality after Screening for Colorectal Cancer — NEJM

Original Article

Long-Term Mortality after Screening for Colorectal Cancer

Aasma Shaukat, M.D., M.P.H., Steven J. Mongin, M.S., Mindy S. Geisser, M.S., Frank A. Lederle, M.D., John H. Bond, M.D., Jack S. Mandel, Ph.D., M.P.H., and Timothy R. Church, Ph.D.
N Engl J Med 2013; 369:1106-1114September 19, 2013DOI: 10.1056/NEJMoa1300720


Abstract
Article
References
Citing Articles (1)
Estimates from multiple, large, randomized trials of colorectal-cancer screening with fecal occult-blood testing consistently show a reduction in colorectal-cancer mortality of 15 to 33%.1-4 The longest follow-up reported to date is 18 to 20 years.5-7 Whether the effect of screening on colorectal-cancer mortality is sustained and whether it applies to all age groups and both sexes are unknown. Furthermore, none of the trials have shown a reduction in all-cause mortality, and one meta-analysis showed a significant increase in mortality not related to colorectal cancer.8 We updated the Minnesota Colon Cancer Control Study9 through 30 years of follow-up to assess the long-term effect of screening on colorectal-cancer mortality and all-cause mortality and to evaluate effects specific to age and sex.

No hay comentarios:

Publicar un comentario